共 10 条
[1]
Soluble tumor necrosis factor receptor prevents post-pump syndrome. Carney DE,Lutz CJ,Picone AL,et al. Journal of Surgical Research . 1999
[2]
Cardiopulmonary bypass produces greater pulmonary than systemic proinflammatory cytokines. Kotani N,Hashimoto H,Sessler DI,et al. Anesthesia and Analgesia . 2000
[3]
An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin-1 and tumor necrosis factor-a increases neutrophil adherence by a CDw18-dependent mechanism. Pohlman TH,Stanness KA,Beatty PG,et al. J Immunol . 1986
[4]
Requirements for tumor necrosis factor-αand interleukin-1 in limb ischemia reperfusion injury and associated lung injury. Seekamp A,Warren JS,Remick DG,et al. American Journal of Pathology . 1993
[5]
Complement and the damaging effects of cardiopulmonary bypass. Kirklin JK. Journal of Thoracic and Cardiovascular Surgery . 1983
[6]
Use of anti-(tumour necrosis factor-α) antibody or 3-deaza-adenosine as additives to promote protection by University of Wisconsin solution in ischaemia reperfusion injury. Chiang CH,Wu CP,Perng WG,et al. Clinical Science . 2000
[7]
The influence of cardiopulmonary bypass on cytokines and cellcell communication. Hill GE. Journal of Cardiothoracic and Vascular Anesthesia . 1997
[8]
Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils. Horvath CJ,Ferro TJ,Jesmok G,et al. Proceedings of the National Academy of Sciences of the United States of America . 1988
[9]
Pulmonary dysfunction after cardiac surgery. Ng CS,Wan S,Yim AP,et al. Chest . 2002
[10]
Selective enhancement of the tumour necrotic activity of TNF alpha with monoclonal antibody. Rathjen DA,Furphy LJ,Aston R. British Journal of Cancer . 1992